MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0021932

Медицинская библиотека · PloS one · 2011

Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?

Schiff Manuel, Benoist Jean-François, Aïssaoui Sofiane, Boespflug-Tanguy Odile, Mouren Marie-Christine, de Baulny Hélène Ogier, Delorme Richard

СтатьяПеревод в очереди

Аннотация

BACKGROUND

In the investigation of autism spectrum disorders (ASD), a genetic cause is found in approximately 10-20%. Among these cases, the prevalence of the rare inherited metabolic disorders (IMD) is unknown and poorly evaluated. An IMD responsible for ASD is usually identified by the associated clinical phenotype such as dysmorphic features, ataxia, microcephaly, epilepsy, and severe intellectual disability (ID). In rare cases, however, ASD may be considered as nonsyndromic at the onset of a related IMD.

OBJECTIVES

To evaluate the utility of routine metabolic investigations in nonsyndromic ASD.

PATIENTS AND

METHODS

We retrospectively analyzed the results of a metabolic workup (urinary mucopolysaccharides, urinary purines and pyrimidines, urinary creatine and guanidinoacetate, urinary organic acids, plasma and urinary amino acids) routinely performed in 274 nonsyndromic ASD children.

RESULTS

The metabolic parameters were in the normal range for all but 2 patients: one with unspecific creatine urinary excretion and the other with persistent 3-methylglutaconic aciduria.

CONCLUSIONS

These data provide the largest ever reported cohort of ASD patients for whom a systematic metabolic workup has been performed; they suggest that such a routine metabolic screening does not contribute to the causative diagnosis of nonsyndromic ASD. They also emphasize that the prevalence of screened IMD in nonsyndromic ASD is probably not higher than in the general population (<0.5%). A careful clinical evaluation is probably more reasonable and of better medical practice than a costly systematic workup.

Для цитирования: Schiff Manuel, Benoist Jean-François, Aïssaoui Sofiane, Boespflug-Tanguy Odile, Mouren Marie-Christine, de Baulny Hélène Ogier, Delorme Richard. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?. PloS one. 2011. DOI: 10.1371/journal.pone.0021932.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.